Lupin: Unit Gets FDA OK To Sell Generic Osteoarthritis Drug - FoxBusiness.com
Links shared publicly online about this topic.
- 581total visits
Lupin: Unit Gets FDA OK To Sell Generic Osteoarthritis Drug - FoxBusiness.com
BANGALORE -(Dow Jones)- Lupin Ltd. (500257.BY) Friday said its U.S unit has received final approval from the U.S. Food and Drug Administration to sell its generic version of nabumetone tablets--in 500 milligram and 750 mg strengths--used for the treatment of osteoarthritis and rheumatoid arthritis.
View full resource at foxbusiness.com
Tags: Arthritis Medication, Osteoarthritis, Osteoarthritis Medication, Drug, FDA, NSAIDs, Relafen
Most Recently Shared on January 14, 2011 at 2:13 pm By:
Lupin: Unit Gets FDA OK To Sell Generic Osteoarthritis Drug: BANGALORE -(Dow Jones)- Lupin Ltd. (500257.BY) Frid... http://fxn.ws/gFmGdq
Also Shared By:
Advertisement
Osteoarthritis OW
@Osteoarthritis_
Lupin: Unit Gets FDA OK To Sell Generic Osteoarthritis Drug: BANGALORE -(Dow Jones)- Lupin Ltd. (500257.BY) Frid... http://fxn.ws/gFmGdq
1 year ago...